Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment.
about
Diagnosis and management of drug-associated interstitial lung diseaseFatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma.A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancerPresentation and management of docetaxel-related adverse effects in patients with breast cancerEffect of topical anaesthetics on interstitial colloid osmotic pressure in human subcutaneous tissue sampled by wick technique.Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease.Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.Mucocutaneous side effects of antineoplastic chemotherapy.The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update.A case of paclitaxel-induced maculopathy treated with methazolamide.Pulmonary toxicity from novel antineoplastic agents.Docetaxel Facilitates Endothelial Dysfunction through Oxidative Stress via Modulation of Protein Kinase C Beta: The Protective Effects of Sotrastaurin.Single premedication dose of dexamethasone 20 mg IV before docetaxel administration.Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review.Dermatological adverse events with taxane chemotherapy.Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane).Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.Severe interstitial pneumonitis associated with docetaxel administration.Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report.Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure.Changes in plasma protein extravasation in rat skin during inflammatory challenges evaluated by microdialysis.Central Macular Thickness Monitoring after a Taxane-Based Therapy in Visually Asymptomatic Patients.Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02.Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.The mystery of angiographically silent macular oedema due to taxanes.Docetaxel-induced pericardial effusion.Start using a checklist, PRONTO: Recommendation for a standard review process for chemotherapy orders.
P2860
Q28212076-A1AB14A5-E1A7-4268-97AB-1E635FC506C6Q30774866-36B93742-BCAF-4611-A8A5-C1C9278F5D97Q33344553-A7ACF97C-35EC-4F70-8669-5168AE4FA086Q33439420-746D182E-9F17-41C1-AA4C-9FC0244A27B3Q33698286-6ED03F59-14F4-43BF-898E-5E81F911319FQ34163486-172193E4-22EF-45B4-AA45-7F05DFFA0E28Q35038451-3872898F-66EF-4C1C-9672-913C8360AE2CQ35607357-C5CACD41-6F2E-4F1B-94C2-A3646B86D4FCQ35925646-577B5D8C-FE97-4625-9156-9442A993F93DQ36142491-F79931A0-64F2-4528-8472-15E994E604BEQ36297617-AEA3A774-9545-4135-BC4E-3429BDE3B5CBQ36314452-F991C6C9-1547-47E3-98C4-29A8D40B7BF5Q36801721-DA4617B7-0871-41BA-87DB-C20EF3E1728DQ37744191-D07F6BD5-9FA0-40FB-A966-08C887738766Q38205153-CA987C3E-39F0-402E-AF0E-A479270B989DQ38263087-975580D6-7531-44E1-85D8-3F61E5267D66Q38934447-CDC467E3-C77E-4346-95CB-AB602CCAD17BQ38964388-E8BEBE5F-4DB5-4E31-AA00-DFF95BC2B6B7Q40098495-144E76C9-232E-4296-9051-EEBF44A65262Q40588005-DF740113-E821-413D-92EB-83A5F911485BQ41162205-50CCBB5A-52BF-46CF-AFB4-362E190527C8Q44516860-1418BD85-F455-4C42-94F2-326BFF3070F8Q44826847-735B08DB-146C-40D8-AC45-58A85E10FDEAQ46864766-2E9F74C1-61C1-4269-AEA9-8474DC6F8104Q47812874-0813B39E-1770-4C69-A72D-3E54A62592CFQ48465530-F8015F66-323F-409D-A2C1-A9053CC60A8EQ50161764-DC62036D-E8BC-41B3-9077-B0FC29D25FE9Q50499436-2619B65B-BD13-4241-8C89-F5E2D7B1E718Q50905915-D785AA2B-23FF-482F-80AD-2BD4F9850FEEQ53125855-8E2726A7-88AB-47E3-8A9D-65207B2121D4
P2860
Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@ast
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@en
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@nl
type
label
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@ast
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@en
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@nl
prefLabel
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@ast
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@en
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@nl
P2093
P1476
Capillary protein leak syndrom ...... o receive docetaxel treatment.
@en
P2093
P304
P356
10.1200/JCO.1998.16.10.3426
P407
P577
1998-10-01T00:00:00Z